| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.1M | +442.9% |
| Cost of Revenue | $29.2M | +414.1% |
| Gross Profit | $35.9M | +468.9% |
| R&D Expense | $26.2M | +45.9% |
| SG&A Expense | $17.9M | +46.2% |
| Operating Income | -$45.3M | -26.2% |
| Net Income | -$54.8M | -24.2% |
| EPS (Basic) | -$8.60 | -3.5% |
| EPS (Diluted) | -$8.60 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.4M | +14.6% |
| Short-term Investments | $73.1M | +4.2% |
| Accounts Receivable | $12.0M | +169.7% |
| Inventory | $13.3M | +969.9% |
| Current Assets | $132.9M | +28.3% |
| Total Assets | $149.6M | +36.0% |
| Current Liabilities | $21.1M | +99.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.3M | -48.8% |
| Capital Expenditures | $3.4M | +744.5% |
| Investing Cash Flow | -$3.5M | +95.0% |
| Financing Cash Flow | $55.6M | -45.0% |
| Free Cash Flow | -$51.7M | -57.3% |
| -3.5% |
| Total Liabilities |
| $73.6M |
| +43.2% |
| Stockholders' Equity | -$245.4M | -20.8% |